Regulation of in situ to invasive breast carcinoma transition
Journal Article
·
· Cancer Cell
OSTI ID:929407
The transition of ductal carcinoma in situ (DCIS) to invasive carcinoma is a key event in breast tumor progression that is poorly understood. Comparative molecular analysis of tumor epithelial cells from in situ and invasive tumors has failed to identify consistent tumor stage-specific differences. However, the myoepithelial cell layer, present only in DCIS, is a key distinguishing and diagnostic feature. To determine the contribution of non-epithelial cells to tumor progression, we analyzed the role of myoepithelial cells and fibroblasts in the progression of in situ carcinomas using a xenograft model of human DCIS. Progression to invasion was promoted by fibroblasts, but inhibited by normal myoepithelial cells. The invasive tumor cells from these progressed lesions formed DCIS rather than invasive cancers when re-injected into naive mice. Molecular profiles of myoepithelial and epithelial cells isolated from primary normal and cancerous human breast tissue samples corroborated findings obtained in the xenograft model. These results provide the proof of principle that breast tumor progression could occur in the absence of additional genetic alterations and that tumor growth and progression could be controlled by replacement of normal myoepithelial inhibitory signals.
- Research Organization:
- Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley, CA (US)
- Sponsoring Organization:
- Life Sciences Division
- DOE Contract Number:
- AC02-05CH11231
- OSTI ID:
- 929407
- Report Number(s):
- LBNL-285E
- Journal Information:
- Cancer Cell, Journal Name: Cancer Cell Journal Issue: 5 Vol. 13
- Country of Publication:
- United States
- Language:
- English
Similar Records
Regulation of In Situ to Invasive Breast CarcinomaTransition
Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ
The SEMA3F-NRP1/NRP2 axis is a key factor in the acquisition of invasive traits in in situ breast ductal carcinoma
Journal Article
·
Tue Mar 13 00:00:00 EDT 2007
· Cancer Cell
·
OSTI ID:932685
Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ
Journal Article
·
Thu Sep 12 20:00:00 EDT 2019
· Nature Communications
·
OSTI ID:1572055
The SEMA3F-NRP1/NRP2 axis is a key factor in the acquisition of invasive traits in in situ breast ductal carcinoma
Journal Article
·
Mon Aug 12 20:00:00 EDT 2024
· Breast Cancer Research
·
OSTI ID:2470836